TOP NEWS
07/27/2022

The P&R landscape of Orphan Drugs in Spain

The PHAROS network member Omakase Consulting shares their last report, in collaboration with the ObserveMHe platform, about the Pricing and Reimbursement situation in Spain of Orphan Drugs approved by the European Commission until 2021 (included).
Read now